Pharmacological Reversal of Histone Methylation Presensitizes Pancreatic Cancer Cells to Nucleoside Drugs: In Vitro Optimization and Novel Nanoparticle Delivery Studies

We evaluated the potential of an investigational histone methylation reversal agent, 3-deazaneplanocin A (DZNep), in improving the chemosensitivity of pancreatic cancer to nucleoside analogs (i.e., gemcitabine). DZNep brought delayed but selective cytotoxicity to pancreatic cancer cells without affe...

Descripción completa

Detalles Bibliográficos
Autores principales: Hung, Sau Wai, Mody, Hardik, Marrache, Sean, Bhutia, Yangzom D., Davis, Franklin, Cho, Jong Hyun, Zastre, Jason, Dhar, Shanta, Chu, Chung K., Govindarajan, Rajgopal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3735519/
https://www.ncbi.nlm.nih.gov/pubmed/23940717
http://dx.doi.org/10.1371/journal.pone.0071196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3735519/
https://www.ncbi.nlm.nih.gov/pubmed/23940717
http://dx.doi.org/10.1371/journal.pone.0071196

Ejemplares similares